Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
Authors:
- Yousra KherabiYKYousra Kherabi
- Mathilde Fréchet-JachymMFMathilde Fréchet-Jachym
- Christophe RiouxCRChristophe Rioux
- Yazdan YazdanpanahYYYazdan Yazdanpanah
- Frédéric MéchaïFMFrédéric Méchaï
- Valérie PourcherVPValérie Pourcher
- Jérôme RobertJRJérôme Robert
- Lorenzo GuglielmettiLGLorenzo Guglielmetti
Open Access
- 1 September 2022
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 28 (9) , 1796-1804
Abstract
TB Resistance and Treatment Outcomes, FranceKeywords
This publication has 32 references indexed in Scilit:
- Linezolid for XDR-TB — Final Study OutcomesNew England Journal of Medicine, 2015
- Changes in treatment outcomes of multidrug-resistant tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2015
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaEuropean Respiratory Journal, 2014
- Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With RifabutinJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesEuropean Respiratory Journal, 2012
- Linezolid for Treatment of Chronic Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2012
- Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosisEuropean Respiratory Journal, 2012
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 PatientsPLOS Medicine, 2012
- Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Impact of Extensive Drug Resistance on Treatment Outcomes in Non-HIV-Infected Patients with Multidrug-Resistant TuberculosisClinical Infectious Diseases, 2007